top of page
Actxa Showcases Non-Invasive Blood Glucose Monitoring Technology at World Diabetes Day 2024
Singapore, 9 November 2024 – Actxa, a Singapore-based deep tech company, showcased its cutting-edge solutions at World Diabetes Day 2024,...
Nov 14, 2024
Actxa’s BGEM: The World’s First Non-Invasive Blood Glucose Monitoring Solution Powered by AI
Singapore, 17 October 2024 —Actxa Pte Ltd, a Singapore-based deep tech company, introduces its Blood Glucose Evaluation & Monitoring...
Oct 18, 2024
Wearables Using Photoplethysmography Sensors for Non-Invasive Blood Glucose Detection Validated
A local study shows that sensors commonly found in wearables can aid in the non-invasive detection of elevated blood glucose levels...
Oct 17, 2024
Singapore’s Actxa and Indonesia’s Universitas Kristen Krida Wacana Collaborate to Lead AI-Driven Chronic Disease Prevention
25 July 2024 – Actxa Pte Ltd (“Actxa”), a Singaporean AI-driven deep tech company, has entered a Memorandum of Understanding (“MOU”) and...
Jul 26, 2024
Actxa and Diabetes and Hypertension Clinic Collaborate for Research on Diabetes Prevention with Artificial Intelligence in India
10 June 2024 – Actxa Pte Ltd (“Actxa”), a Singaporean AI-driven deep tech company, has entered a Memorandum of Understanding (“MOU”)...
Jun 10, 2024
Actxa and Instytut Medycyny Innowacyjnej sp.z o.o Introduce BGEM in Poland
4 April 2024 – Actxa Pte Ltd (“Actxa”), an AI-driven deep tech company headquartered in Singapore, has signed a Memorandum of Agreement...
Apr 4, 2024
bottom of page